#90 Cargill Breaks Down GLP-1's Impact on Commercial Baking
About this episode
The episode discusses the impact of GLP-1 medications on commercial baking and how the industry can adapt to changing consumer demands.
What do GLP-1 medications mean for the future of commercial baking? In this episode of Bake to the Future, host Anne Fairfield-Sonn speaks with Keith Albright, Senior Insights Manager for Bakery at Cargill, about how rising GLP-1 adoption is influencing appetite, portion sizes, nutrition priorities, and overall bakery demand. They explore how the industry can adapt to consumer changes and what actions commercial bakers should be taking now. Tune in for timely insights to help your business stay ahead. With special guest: Keith Albright, Senior Insights Manager for Bakery at Cargill Hosted by: Anne Fairfield-Sonn, Director of Marketing and Communications at the American Bakers Association
More episodes of Bake to the Future
- #91 Amoroso's and Gonnella: 100+ Years of Baking Innovation
- #89 Key Policy Issues Impacting the Baking Industry Today
- #88 How Ardent Mills is Advancing Regenerative Agriculture in Baking
- #87 The Future of Flavor and Careers in Baking with Kerry
- #86 Consumer Innovation and the Future of Baking with Puratos
- #85 IBIEducate Session Recap: Canada and the United States Cross-Border Collaboration
Explore listener stats, chart rankings, contacts and more on the Bake to the Future podcast page.